A clinician’s guide to cardiovascular MRI referrals: a practical guide of ESC recommendations by Nicola Ciocca (20980736)

“…The growth in its clinical indications is evident from the expanding recommendations by the European Society of Cardiology (ESC). The year 2024 marked a significant milestone for CMR, as the latest ESC guidelines incorporated several novel indications for its use. …”

Data Sheet 1_Disease spectrum of patients with hospital-acquired multidrug-resistant organism infections in the intensive care unit: a retrospective study.doc by Xiaowu Wang (167537)

“…</p>Results<p>The incidence density of hospital-acquired MDRO infections showed significant variation over the six-year period, with the highest density in the post-COVID-19 period (43.98 per 1,000 ICU days) and the lowest during the COVID-19 period (21.96 per 1,000 ICU days). …”

Table_1_Knowledge and attitudes toward over-the-counter medications among pharmacy students: insights from a cross-sectional study in Taif University, Saudi Arabia.DOCX by Mohammed S. Alharthi (16812670)

“…</p>Conclusion<p>The study found positive attitudes toward OTC medications. Due to increased pharmaceutical exposure and self-medication, upper-year students and OTC course graduates comprehend OTC medications better. …”

Data Sheet 1_Estimated plasma volume status as a prognostic indicator in myocardial infarction and heart failure: insights from the MIMIC-IV database.docx by Bin Luo (303443)

“…Q1) was associated with an increased risk of 180-day mortality (HR 1.45, 95% CI 1.19–1.75, P < 0.001) and 1-year mortality (HR 1.51, 95% CI 1.27–1.80, P < 0.001). …”

Table 1_Estradiol trajectories and early pregnancy loss: a retrospective study.docx by Yanling Wei (508050)

“…</p>Results<p>Among the four identified E2 trajectories, women in Trajectory 3 (“High Level with Steady Increase”) showed a significantly reduced risk of early miscarriage compared to those in Trajectory 2 (“Low Level with Slow Increase”) (adjusted OR = 0.24, 95% CI: 0.12–0.46, p < 0.001). …”

Data Sheet 2_Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot study.docx by Stephanie Dauth (13274397)

“…On day 7, numerically greater decreases in the thyme-ivy syrup group were observed for some mediators, including IL-10 (−17.7 vs. − 6.0 pg/mL; effect size 0.53) and IL-6 levels (−4.9 vs. − 0.9 pg/mL; effect size 0.87). …”

Data Sheet 1_Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective, open-label, randomized pilot study.docx by Stephanie Dauth (13274397)

“…On day 7, numerically greater decreases in the thyme-ivy syrup group were observed for some mediators, including IL-10 (−17.7 vs. − 6.0 pg/mL; effect size 0.53) and IL-6 levels (−4.9 vs. − 0.9 pg/mL; effect size 0.87). …”

Supplementary Material for: Assessment of the Factors Influencing Early Detection Practices of Oral Carcinomas by Dentists: A Cross-Sectional Study by figshare admin karger (2628495)

“…Prevention and early detection practices are important because they increase five-year survival and reduce recurrence. …”

Image 1_Case Report: Efficacy and safety of recombinant growth hormone therapy in a girl with Loeys–Dietz syndrome.pdf by Kamil Dyrka (20497565)

“…</p>Case summary<p>LDS was recognized in the patient in the 2nd year of life. After the 3rd year of life, growth deceleration was observed. …”

Supplementary Material for: A longitudinal investigation of oral inferential comprehension in French-speaking preschoolers: results from the ELLAN study by figshare admin karger (2628495)

“…Results: Inferential comprehension total scores showed significant improvement across all three time points, with the most significant increase between 3;6 and 4;6 years of age. …”

Data Sheet 1_Frailty prediction in patients with chronic digestive system diseases: based on multi-task learning model.docx by Sihan Hu (13860437)

“…Background<p>Chronic digestive system diseases (CDSD) pose a major health challenge worldwide, significantly increasing morbidity and mortality rates. …”

Supplementary Material for: Focus on the Blind Spot of Stone Disease: Analysis of Lower Urinary Tract Stone Interventions from 2006 to 2020 using German nationwide inpatient data. by Herout R. (20352174)

“…Inpatient shock wave lithotripsy (SWL) is very rarely performed for bladder calculi with an average of 22 cases per year in all hospitals in Germany. Case numbers of open cystolithotomy (OCL) also increased from 614 cases in 2006 to 692 cases in 2020 (p=0.006), but the share decreased by 15.5 %. …”

Table 1_Efficacy and safety of insulin degludec/aspart in patients with type 2 and type 1 diabetes mellitus: real-world evidence from Indonesia.pdf by Hendra Zufry (7544921)

“…Slight but statistically significant increases in BMI were observed in both groups (both p < 0.001). …”

Supplementary Material for: Darier’s Disease Successfully Treated with Tofacitinib: A Case Report by figshare admin karger (2628495)

“…Due to persistent itching and new lesions, the dose was increased to 15 mg daily, resulting in significant improvement. …”

Included studies basic characteristics. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”

Forest plot for FVC. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”

DataSheet1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review... by Xuqin Du (8803772)

“…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO₂ (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO₂ (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”

DataSheet2_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review... by Xuqin Du (8803772)

“…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO₂ (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO₂ (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”

All data extracted. by Xuqin Du (8803772)

“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO₂ (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO₂ (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”

Table1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review and... by Xuqin Du (8803772)

“…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO₂ (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO₂ (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”